Trisalus Life SciencesTLSI
13F holders, Q1 2024 (March 31)25holders
2famous investors
$9.75avg. 13F price*
At the end of Q1 2024, 25 institutions reported holding Trisalus Life Sciences Inc. (TLSI) in their 13F filings. The largest holders were Duquesne Family Office ($3.1M), Vanguard Group Inc. ($1.6M) and Geode Capital Management, LLC ($1.3M). 2 famous investors held it, including Stanley Druckenmiller (0.1% of Duquesne Family Office's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Trisalus Life Sciences Inc.
- CUSIP
- 89680M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $4.0M |
| Exits | 3 | $1.4M |
Ownership 25 holders
| Duquesne Family Office | 0.08% | New | 315,955 | $3.1M |
| Vanguard Group Inc. | 0.00% | Add +1.2% | 167,159 | $1.6M |
| Geode Capital Management, LLC | 0.00% | Add +6.6% | 134,099 | $1.3M |
| Goldman Sachs Group Inc. | 0.00% | New | 54,475 | $531K |
| Connecticut Wealth Management, LLC | 0.02% | Reduce -22.0% | 44,606 | $435K |
| BlackRock Inc. | 0.00% | Add +3220.5% | 42,170 | $411K |
| Laird Norton Wetherby Wealth Management, LLC | 0.02% | No change | 34,950 | $341K |
| Northern Trust Corp. | 0.00% | Add +56.3% | 28,423 | $277K |
| Anson Capital, Inc. | 0.34% | Reduce -30.3% | 24,415 | $238K |
| Millennium Management | 0.00% | New | 17,696 | $173K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 15,554 | $152K |
| Morgan Stanley | 0.00% | Add +6.6% | 13,309 | $130K |
| JPMorgan Chase & Co. | 0.00% | New | 10,559 | $103K |
| Tyche Wealth Partners LLC | 0.02% | Reduce -62.5% | 10,000 | $98K |
| Qube Research & Technologies Ltd | 0.00% | New | 5,490 | $54K |
| Bank of America Corp. | 0.00% | New | 2,168 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -21.8% | 1,542 | $15K |
| Wells Fargo & Company | 0.00% | Add +0.1% | 1,319 | $13K |
| Hoertkorn Richard Charles | 0.00% | No change | 668 | $7K |
| GPS Wealth Strategies Group, LLC | 0.00% | No change | 657 | $6K |
| UBS Group AG | 0.00% | Reduce -97.7% | 391 | $4K |
| Signaturefd, LLC | 0.00% | New | 100 | $975 |
| Deerfield Management Company, L.P. | 0.00% | No change | 1 | $10 |
| Clear Street LLC | 0.00% | New | 1 | $10 |
| Macquarie Group Ltd. | 0.00% | New | 291 | $3 |
"% of holder's portfolio" is TLSI's weight in each manager's 13F, not the share of Trisalus Life Sciences Inc. the manager owns.